Accessibility Menu
Arrow-Thin-Down
S&P 500
6,850.99
+0.1%
+4.38
Arrow-Thin-Down
DJI
48,254.82
+0.7%
+326.86
Arrow-Thin-Down
NASDAQ
23,406.46
-0.3%
-61.84
Arrow-Thin-Down
Bitcoin
$101,533.00
-1.2%
-$1,283.71
Arrow-Thin-Down
AAPL
$273.01
-0.8%
-$2.24
Arrow-Thin-Down
AMZN
$243.78
-2.1%
-$5.32
Arrow-Thin-Down
GOOG
$286.99
-1.6%
-$4.75
Arrow-Thin-Down
META
$608.25
-3.0%
-$18.83
Arrow-Thin-Down
MSFT
$510.96
+0.4%
+$2.28
Arrow-Thin-Down
NVDA
$193.46
+0.2%
+$0.30
Arrow-Thin-Down
TSLA
$431.58
-1.8%
-$8.04
Daily Stock GainersDaily Stock LosersMost Active Stocks

This Growth Stock Is Down 35%. Buy or Wait?

By Neil Rozenbaum – Nov 12, 2025 at 12:14PM

Despite the short-term volatility, this remains a high-reward stock to own.

In this video, I will explain why Oscar Health (OSCR +2.42%) experienced a significant decline on Monday and why I will keep my current position. Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock prices used were from the trading day of Nov. 10, 2025. The video was published on Nov. 11, 2025.

Neil Rozenbaum has positions in CoreWeave, Oscar Health, and Rocket Lab. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services